Fujisawa, Japan

Kazuko Yonemori


 

 

Average Co-Inventor Count = 10.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Kanagawa, JP (2015)
  • Fujisawa, JP (2017 - 2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kazuko Yonemori: Innovator in Heterocyclic Compounds

Introduction

Kazuko Yonemori is a prominent inventor based in Fujisawa, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic compounds. With a total of 6 patents to her name, her work focuses on addressing critical health issues.

Latest Patents

Among her latest patents, one notable invention relates to a heterocyclic compound that can be useful for the treatment or prevention of SPT-related diseases. These diseases include cancer and congenital conditions associated with sphingolipid accumulation, such as Niemann-Pick disease. This innovative approach highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Kazuko Yonemori is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. Her role at Takeda allows her to collaborate with other experts in the field and contribute to groundbreaking research and development efforts.

Collaborations

Throughout her career, Kazuko has worked alongside talented colleagues, including Satoshi Yamamoto and Junya Shirai. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of her patented compounds.

Conclusion

Kazuko Yonemori's contributions to the field of medicinal chemistry are noteworthy. Her innovative work in heterocyclic compounds demonstrates her dedication to addressing significant health challenges. With her ongoing research and collaboration, she continues to make a positive impact in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…